Literature DB >> 9428927

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia.

Q Su1, A Benner, W J Hofmann, G Otto, R Pichlmayr, P Bannasch.   

Abstract

Foci of altered hepatocytes (FAH) represent preneoplastic lesions, as shown in various animal models of hepatocarcinogenesis, but their significance in the human liver has not been established. The cellular composition, size distribution and proliferation kinetics of FAH in 163 explanted and resected human livers with or without hepatocellular carcinoma (HCC) and their possible association with small-cell change of hepatocytes (SCC) were therefore studied. FAH, including glycogen-storing foci, were found in 84 of 111 cirrhotic livers, demonstrating higher incidences in cases with (29/32) than in those without HCC (55/79). FAH were observed more frequently in HCC-free cirrhosis associated with hepatitis B or C virus or chronic alcoholic abuse (high-risk group) (37/47) than in that due to other causes (low-risk group) (12/21). MCF, predominant in cirrhotic livers of the high-risk group, were more proliferative, larger and more often involved in formation of nodules of altered hepatocytes (39.3%) than were GSF (8.5%). The results suggest that the FAH are preneoplastic lesions, MCF being more advanced than GSF. Oncocytic and amphophilic cell foci were also observed, but their significance remains to be clarified. Two types of SCC, namely diffuse and intrafocal SCC, were identified, but only intrafocal SCC was found to be related to increased proliferative activity and more frequent nodular transformation of the FAH involved, suggesting a close association with progression from FAH to HCC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428927     DOI: 10.1007/s004280050116

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Hyperproliferative hepatocellular alterations after intraportal transplantation of thyroid follicles.

Authors:  F Dombrowski; L Klotz; H J Hacker; Y Li; D Klingmüller; K Brix; V Herzog; P Bannasch
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.

Authors:  D Nehrbass; F Klimek; P Bannasch
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 4.  [Molecular and metabolic changes in human clear cell liver foci].

Authors:  S Ribback; D F Calvisi; A Cigliano; J Rausch; C-D Heidecke; M Birth; F Dombrowski
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

5.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 6.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

7.  Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.

Authors:  Elisabeth Tybl; Fu-Dong Shi; Sonja M Kessler; Sascha Tierling; Jörn Walter; Rainer M Bohle; Stefan Wieland; Jianying Zhang; Eng M Tan; Alexandra K Kiemer
Journal:  J Hepatol       Date:  2010-10-26       Impact factor: 25.083

8.  Attenuation of liver cancer development by oral glycerol supplementation in the rat.

Authors:  Alejo M Capiglioni; Florencia Lorenzetti; Ariel D Quiroga; Juan P Parody; María T Ronco; Gerardo B Pisani; María C Carrillo; María P Ceballos; María de Luján Alvarez
Journal:  Eur J Nutr       Date:  2017-03-02       Impact factor: 5.614

9.  Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

Authors:  Sabrina C Wentz; Huangbing Wu; Michele T Yip-Schneider; Matthew Hennig; Patrick J Klein; Judith Sebolt-Leopold; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2007-11-07       Impact factor: 3.452

10.  Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.

Authors:  Yi-Ran Cai; Li Gong; Xiao-Ying Teng; Hong-Tu Zhang; Cheng-Feng Wang; Guo-Lian Wei; Lei Guo; Fang Ding; Zhi-Hua Liu; Qin-Jing Pan; Qin Su
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.